LIS
UTHR icon

Legacy Investment Solutions’s United Therapeutics UTHR Stock Holding History

Legacy Investment Solutions’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$7.47K Buy
+26
New +$7.77K ﹤0.01% 352
2024
Q4 		$11.5K Buy
33
+7
+27% +$2.57K 0.01% 264
2024
Q3 		$10.4K Buy
+26
New +$8.78K 0.01% 306

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Legacy Investment Solutions's UTHR Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in United Therapeutics (UTHR) in Q2 2025: 26 shares worth $7.47K. The stake represents ﹤0.01% of the portfolio and ranks #352 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in UTHR as recently as Q4 2024.

Legacy Investment Solutions first reported a position in UTHR in Q3 2024 and has held it in 3 quarters since. The position peaked at $11.5K in Q4 2024. 670 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • Legacy Investment Solutions held 26 shares of United Therapeutics worth $7.47K as of Q2 2025.
  • United Therapeutics was a new Legacy Investment Solutions position in Q2 2025.
  • United Therapeutics made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #352 holding.
  • Legacy Investment Solutions first reported a position in United Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's United Therapeutics position peaked at $11.5K in Q4 2024.
  • 670 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.